DXM Abuse Prevention Act of 2019
United States116th CongressHR-863House of Representatives
Updated: Jan 30, 2019
Summary
DXM Abuse Prevention Act of 2019 This bill addresses the sale and distribution of dextromethorphan (DXM). Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer. The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
Bill texts
All available records shown.
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
House of Representatives
All available records shown.